Head-to-head comparison
Invyncible vs Ondra Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Invyncible is a Florida telehealth platform pricing every GLP-1 dose program in the open, with all six of its compounding pharmacies named and patient-selectable.
From $149/mo (lowest dose rung) sema · From $180/mo (lowest dose rung) tirz · Verified August 2026
Marked down on: The entry price buys the smallest vial: the same plain semaglutide program runs $262.50 at 5 mg and $350 at 10 mg, which the FAQ confirms
Desk Score
Compounded semaglutide from $149 a month and tirzepatide from $219 month-to-month, one price at every dose, with every dispensing pharmacy named on the site.
$149/mo sema · $219/mo tirz · Verified August 2026
Marked down on: Injectable only — no oral route
Ondra Health takes this head-to-head with the higher Desk Score, 91/100 (A−) against 73/100 (C) for Invyncible. Invyncible still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Invyncible
73/100
C
Ondra Health
91/100
A−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Invyncible | Ondra Health |
|---|---|---|
| Semaglutide | From $149/molowest dose rung$149/mo (0.45 mg dose, compounded with glycine + B12) | $149/mo$149/mo month-to-month; $113/mo billed quarterly ($339); $108/mo on a 6-month plan ($649 up front); $96/mo on a 12-month plan ($1,149 up front); same price at every dose; compounded injectable |
| Tirzepatide | From $180/molowest dose rung$180/mo (2.5 mg weekly, 4-week program, compounded) | $219/mo$219/mo month-to-month; $183/mo billed quarterly ($549); $167/mo on a 6-month plan ($999 up front); $142/mo on a 12-month plan ($1,699 up front); same price at every dose; compounded injectable |
| Coverage | 46 states plus DC | All 50 states and Puerto Rico |
| Brand-name | Yes | Compounded only |
| Oral option | Yes | Injectable only |
| Best for | An open price list and a named, patient-selectable compounding pharmacy rather than an unnamed network. | Anyone who wants to know which pharmacy fills the vial before they pay, and is fine with a weekly injection. |
| Desk Score | 73/100C | 91/100A− |
The verdict
Desk pick — Ondra HealthOndra Health takes this head-to-head with the higher Desk Score, 91/100 (A−) against 73/100 (C) for Invyncible. Invyncible still holds its ground where its strengths line up with yours.
Choose Invyncible if…
An open price list and a named, patient-selectable compounding pharmacy rather than an unnamed network.
From $149/mo (lowest dose rung) sema · From $180/mo (lowest dose rung) tirz · 46 states plus DC
Choose Ondra Health if…
Anyone who wants to know which pharmacy fills the vial before they pay, and is fine with a weekly injection.
$149/mo sema · $219/mo tirz · All 50 states and Puerto Rico
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Invyncible · Ondra Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Invyncible
- CoreAge Rx vs Ondra Health
- Invyncible vs Sesame Care
- Ondra Health vs Sesame Care
- Invyncible vs Vaylen
- Ondra Health vs Vaylen
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.